1201. |
|
|
1202. |
- Lagercrantz, H, et al.
(författare)
-
The future of Acta paediatrica
- 2004
-
Ingår i: ACTA PAEDIATRICA. - 0803-5253. ; 93:1, s. 1-1
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
1203. |
- Lagercrantz, H
(författare)
-
The good stress of being born
- 2016
-
Ingår i: Acta paediatrica (Oslo, Norway : 1992). - : Wiley. - 1651-2227 .- 0803-5253. ; 105:12, s. 1413-1416
-
Tidskriftsartikel (refereegranskat)
|
|
1204. |
- Lagercrantz, H
(författare)
-
The hard problem
- 2008
-
Ingår i: Acta paediatrica (Oslo, Norway : 1992). - : Wiley. - 0803-5253 .- 1651-2227. ; 97:2, s. 142-143
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
1205. |
|
|
1206. |
- Lagerkvist, Anna-Lena, 1956, et al.
(författare)
-
Positive expiratory pressure (PEP) treatment in children with multiple severe disabilities
- 2005
-
Ingår i: Acta Paediatr. - 0803-5253. ; 94:5, s. 538-42
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Children with multiple severe disabilities cannot be spontaneously physically active and therefore lack the ventilatory stimulation of physical activity. They often produce large quantities of airway mucus, which they have difficulty to evacuate on their own. The accumulation of mucus may lead to respiratory insufficiency. AIM: To investigate whether chest physiotherapy with positive expiratory pressure (PEP) could improve the blood oxygen tension (PO(2)) and/or decrease carbon dioxide tension (PCO(2)) in severely disabled children with airway mucus accumulation. METHODS: Eighteen disabled children (mean age 7.5 y, SD 4.3, range 1.7-17.8 y) participated in the study. Transcutaneous (tc) PO(2), tcPCO(2) and respiratory rate (RR) were recorded before and after PEP treatment. The reproducibility of the effect of the treatment was tested by repeating the recordings. RESULTS: The mean tcPO(2) increased 1.0 kPa (range -0.2 to 3.4 kPa) immediately after PEP treatment (p=0.0001). No significant changes in tcPCO(2) or RR were noted. The reproducibility of the effect of PEP treatment was good, with a significant increase in tcPO(2) at all retests. All children accepted the treatment well. CONCLUSION: PEP increases blood oxygen tension immediately after treatment in severely disabled children with airway mucus accumulation. Long-term effects remain to be proven.
|
|
1207. |
|
|
1208. |
|
|
1209. |
|
|
1210. |
- Laitinen, Anna U., et al.
(författare)
-
Coeliac patients detected during type 1 diabetes surveillance had similar issues to those diagnosed on a clinical basis
- 2017
-
Ingår i: Acta Paediatrica, International Journal of Paediatrics. - : Wiley. - 0803-5253. ; 106:4, s. 639-646
-
Tidskriftsartikel (refereegranskat)abstract
- Aim: Screening children with type 1 diabetes for coeliac disease is controversial, because they often appear asymptomatic. Our aim was to establish whether active screening should be recommended. Methods: This study focused on 22 children whose coeliac disease was detected by serological screening during diabetes surveillance and 498 children diagnosed because of a clinical suspicion. We compared the clinical and histological data at diagnosis and the children's adherence and responses to a gluten-free diet. Results: The serological screening group suffered less from decreased growth (p = 0.016) and clinical symptoms (p < 0.001) at diagnosis than the clinical group. The groups did not differ in terms of age at diagnosis (p = 0.903), gender (p = 0.353), anaemia (p = 0.886), endomysial antibody titres (p = 0.789) and the severity of small-bowel mucosal atrophy (p = 0.104). They also showed equal adherence (p = 0.086) and clinical responses (p = 0.542) to a gluten-free diet after a median follow-up of 13 months. Conclusion: Coeliac patients detected during diabetes surveillance had signs of malabsorption and advanced mucosal damage that was similar to those diagnosed on a clinical basis. They often suffered from unrecognised gluten-dependent symptoms and showed excellent adherence and responses to a gluten-free diet. Our findings support active screening for coeliac disease in patients with type 1 diabetes.
|
|